Vanguard Group Inc Alpha Teknova, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 396,798 shares of TKNO stock, worth $698,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares

396,798

Previous 394,325 0.63%

Holding current value

$698,364

Previous $1.47 Million 28.5%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.41 - $3.88 $5,959 - $9,595	2,473 Added 0.63%	396,798 $1.05 Million
Q4 2023 Feb 14, 2024	SELL	$1.85 - $3.73 $14,901 - $30,045	-8,055 Reduced 2.0%	394,325 $1.47 Million
Q3 2023 Nov 14, 2023	SELL	$1.66 - $3.83 $2,245 - $5,181	-1,353 Reduced 0.34%	402,380 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$1.8 - $3.98 $45,543 - $100,701	-25,302 Reduced 5.9%	403,733 $1.08 Million
Q1 2023 May 15, 2023	BUY	$2.74 - $6.25 $287,730 - $656,318	105,011 Added 32.41%	429,035 $1.27 Million

Q4 2022 Feb 10, 2023	BUY	$3.23 - $5.64 $38,876 - $67,883	12,036 Added 3.86%	324,024 $1.83 Million
Q3 2022 Nov 14, 2022	SELL	$3.34 - $9.2 $4,832 - $13,312	-1,447 Reduced 0.46%	311,988 $1.04 Million
Q2 2022 Aug 12, 2022	SELL	$6.39 - $16.24 $201,125 - $511,153	-31,475 Reduced 9.13%	313,435 $2.63 Million
Q1 2022 May 13, 2022	BUY	$12.79 - $21.64 $1,355 - $2,293	106 Added 0.03%	344,910 $4.76 Million
Q4 2021 Feb 14, 2022	SELL	$17.49 - $26.72 $6.53 Million - $9.97 Million	-373,253 Reduced 51.98%	344,804 $7.06 Million
Q3 2021 Nov 12, 2021	BUY	$17.47 - $27.49 $11.5 Million - $18.1 Million	658,057 Added 1096.76%	718,057 $17.9 Million
Q2 2021 Aug 13, 2021	BUY	$23.73 - $27.98 $1.42 Million - $1.68 Million	60,000 New	60,000 $1.42 Million

Others Institutions Holding TKNO

# of Institutions

Shares Held

6.29M

Call Options Held

Put Options Held

View Full List

About Alpha Teknova, Inc.

Ticker TKNO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 28,080,500
Market Cap $49.4M
Description
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...

More about TKNO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Alpha Teknova, Inc. Transaction History